Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-dependent Hypercortisolism

To identify preoperative factors influencing the duration of steroid replacement therapy after adrenalectomy/adrenal-sparing surgery in patients with non-ACTH-dependent hypercortisolism.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cushing's Syndrome Adrenal Gland Diseases Adrenocortical Hyperfunction Cushing Syndrome Endocrine System Diseases Glucocorticoid Postoperative Prediction

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Urology, Peking University First Hospital, Beijing, 100034

Beijing, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In all, 111 patients (meadian age: 54years; 64.9% female) were included and received postoperative steroid replacement therapy, among whom 65 were diagnosed with subclinical Cushing's syndrome (SCS) and 46 with overt Cushing's syndrome (CS).

Exclusion criteria

none

Treatment and study plan

observational diagnostic model development

Other

observational diagnostic model development

Primary outcomes

Tumor volume

Time frame: from 2017 to 2025

Sponsors and collaborators

Lead sponsor

Peking University First Hospital

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2025
Study completion: 2025
First posted: Dec 15, 2025
Registry last updated: Dec 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed